Clinical, Radiological, and Molecular Insights into Craniopharyngioma
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: 31 May 2025 | Viewed by 565
Special Issue Editors
Interests: neuro-oncology; brain tumors; skull base; microneurosurgery; neuroanatomy; neuronavigation; stereotactic surgery; intracranial aneurysm
Interests: neurosurgery; neuro-oncology; brain tumors; genetic predispostition to cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The sellar region is of particular interest to neurosurgeons and encompasses a variety of conditions, including pituitary adenomas, craniopharyngiomas, aneurysms, astrocytomas, and meningiomas. Among these, craniopharyngioma remains one of the most challenging entities. It is a slow-growing, benign intracranial tumor, but it exhibits locally invasive behavior, complicating treatment and prognosis.
One of the major difficulties with craniopharyngioma is its high recurrence rate, which can reach up to 50%. Identifying risk factors for recurrence is a significant area of current research. Surgical approach selection is critical, and preserving the pituitary stalk during surgery has been associated with better functional outcomes but can increase the risk of tumor persistence or recurrence. Gross total resection (GTR) remains the goal for reducing recurrence, although subtotal resection (STR) followed by adjuvant radiotherapy (XRT) is also considered in cases where complete resection may lead to serious complications.
In addition to surgical and radiological advances, new adjuvant therapies are being explored to address the challenging nature of craniopharyngioma. Intratumoral therapy with sclerosing agents, such as bleomycin, has been trialed, and targeted therapies, including inhibitors for BRAF, MEK, and interleukin-6, are under investigation. However, the long-term efficacy and safety of these treatments are still uncertain, highlighting the need for further studies to evaluate their potential.
Furthermore, a deeper understanding of the histopathologic subtypes of craniopharyngioma is also crucial. Current research aims to clarify how these subtypes influence tumor behavior, recurrence risk, and response to therapies. As a result, future studies are essential for improving diagnostic precision, refining therapeutic approaches, and enhancing long-term outcomes for patients with this complex tumor.
Further investigation into the clinical, radiological, molecular, and therapeutic aspects of craniopharyngioma is essential to better understand and manage this condition.
Dr. Ernest Jan Bobeff
Dr. Bartosz Szmyd
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuro-oncology
- brain tumors
- skull base
- craniopharyngioma
- stalk
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
